+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bleeding Disorders Treatment Market Research Report by Disease Type (Hemophilia A, Hemophilia B, and Von Willebrand Disease), Drug Class, Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 229 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 4989638
UP TO OFF until Mar 31st 2023
The Global Bleeding Disorders Treatment Market size was estimated at USD 12.42 billion in 2022, USD 13.56 billion in 2023, and is projected to grow at a CAGR of 9.27% to reach USD 25.25 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Bleeding Disorders Treatment Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Bleeding Disorders Treatment Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Bleeding Disorders Treatment Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Bleeding Disorders Treatment Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Bleeding Disorders Treatment Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Type, the market is studied across Hemophilia A, Hemophilia B, and Von Willebrand Disease.
  • Based on Drug Class, the market is studied across Antibrinolytics, Desmopressin, Fibrin Sealant, Plasma Derived Coagulation Factor Concentrates, and Recombinant Coagulation Factor Concentrates.
  • Based on Distribution Channel, the market is studied across Compounding Pharmacies, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Bleeding Disorders Treatment Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Bleeding Disorders Treatment Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Bleeding Disorders Treatment Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Bleeding Disorders Treatment Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bleeding Disorders Treatment Market, including Alnylam Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Bayer AG, Biogen Inc., Bristol-Myers Squibb Company, CSL Behring, Emergent BioSolutions Inc., Grifols International, S.A., Kedrion S.p.A., Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., and Xenetic Biosciences, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bleeding Disorders Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bleeding Disorders Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bleeding Disorders Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Bleeding Disorders Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Bleeding Disorders Treatment Market?
6. What is the market share of the leading vendors in the Global Bleeding Disorders Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Bleeding Disorders Treatment Market?
Frequently Asked Questions about the Global Bleeding Disorders Treatment Market

What is the estimated value of the Global Bleeding Disorders Treatment Market?

The Global Bleeding Disorders Treatment Market was estimated to be valued at $12.42 Billion in 2022.

What is the growth rate of the Global Bleeding Disorders Treatment Market?

The growth rate of the Global Bleeding Disorders Treatment Market is 9.2%, with an estimated value of $25.25 Billion by 2030.

What is the forecasted size of the Global Bleeding Disorders Treatment Market?

The Global Bleeding Disorders Treatment Market is estimated to be worth $25.25 Billion by 2030.

Who are the key companies in the Global Bleeding Disorders Treatment Market?

Key companies in the Global Bleeding Disorders Treatment Market include Alnylam Pharmaceuticals Inc., Amgen Inc., Baxter International Inc., Bayer AG, Biogen Inc., Bristol, Myers Squibb Company, CSL Behring and Grifols International, S.A..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of liver disorders and anemia
5.1.1.2. Rising healthcare expenditure by the government
5.1.1.3. Considerable increase in healthcare accessibility in economies
5.1.2. Restraints
5.1.2.1. Lack of skilled professionals and trained expertise
5.1.3. Opportunities
5.1.3.1. Rising awareness regarding bleeding disorders
5.1.3.2. Rise in demand due to lower infection risks and high investments in research and development
5.1.4. Challenges
5.1.4.1. High cost of medications of bleeding disorders treatment
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Bleeding Disorders Treatment Market, by Disease Type
6.1. Introduction
6.2. Hemophilia A
6.3. Hemophilia B
6.4. Von Willebrand Disease

7. Bleeding Disorders Treatment Market, by Drug Class
7.1. Introduction
7.2. Antibrinolytics
7.3. Desmopressin
7.4. Fibrin Sealant
7.5. Plasma Derived Coagulation Factor Concentrates
7.6. Recombinant Coagulation Factor Concentrates

8. Bleeding Disorders Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Compounding Pharmacies
8.3. Hospital Pharmacies
8.4. Retail Pharmacies

9. Americas Bleeding Disorders Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bleeding Disorders Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bleeding Disorders Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Alnylam Pharmaceuticals Inc.
13.2. Amgen Inc.
13.3. Baxter International Inc.
13.4. Bayer AG
13.5. Biogen Inc.
13.6. Bristol-Myers Squibb Company
13.7. CSL Behring
13.8. Emergent BioSolutions Inc.
13.9. Grifols International, S.A.
13.10. Kedrion S.p.A.
13.11. Novo Nordisk A/S
13.12. Octapharma AG
13.13. Pfizer Inc.
13.14. Sanofi S.A.
13.15. Xenetic Biosciences, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET DYNAMICS
FIGURE 11. GLOBAL BLEEDING DISORDERS TREATMENT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE TYPE, 2030
FIGURE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
FIGURE 19. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 20. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DRUG CLASS, 2030
FIGURE 21. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, 2018-2030 (USD BILLION)
FIGURE 24. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
FIGURE 25. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 27. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 28. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2030
FIGURE 29. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 30. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 31. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 32. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 33. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 34. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 35. AMERICAS BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 36. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 37. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 38. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 39. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 40. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 41. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 42. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 43. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 44. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 45. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 46. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 47. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 48. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 55. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 56. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 57. TAIWAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 59. VIETNAM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 64. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. EGYPT BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. FINLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. ISRAEL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. NIGERIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. NORWAY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. POLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. SWEDEN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 81. SWITZERLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 82. TURKEY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 83. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 84. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 85. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 86. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 87. GLOBAL BLEEDING DISORDERS TREATMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY ANTIBRINOLYTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DESMOPRESSIN, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY PLASMA DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COMPOUNDING PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 41. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 42. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 43. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 44. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 45. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 46. AMERICAS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 47. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 48. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 49. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 50. ARGENTINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 51. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 52. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 53. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 54. BRAZIL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 55. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 56. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 57. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 58. CANADA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 59. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 60. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 61. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 62. MEXICO BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 63. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 64. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 65. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 66. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 67. UNITED STATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 68. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 70. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 71. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 72. ASIA-PACIFIC BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 73. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 74. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 75. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 76. AUSTRALIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 77. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 79. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 80. CHINA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 81. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 82. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 83. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 84. INDIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 85. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 86. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 87. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 88. INDONESIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 89. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 91. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 92. JAPAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 93. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 94. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 95. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 96. MALAYSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 97. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 98. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 99. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 100. PHILIPPINES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 101. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 102. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 103. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 104. SINGAPORE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 105. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 107. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 108. SOUTH KOREA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 109. TAIWAN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 110. TAIWAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 111. TAIWAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 112. TAIWAN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 113. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 114. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 115. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 116. THAILAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 117. VIETNAM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. VIETNAM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 119. VIETNAM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 120. VIETNAM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 126. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 128. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 129. DENMARK BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 130. EGYPT BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 131. EGYPT BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 132. EGYPT BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 133. EGYPT BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 134. FINLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 135. FINLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 136. FINLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 137. FINLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 138. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 140. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 141. FRANCE BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 142. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 143. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 144. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 145. GERMANY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 146. ISRAEL BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 147. ISRAEL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 148. ISRAEL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 149. ISRAEL BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 150. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 152. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 153. ITALY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 154. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 155. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 156. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 157. NETHERLANDS BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 158. NIGERIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 159. NIGERIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 160. NIGERIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 161. NIGERIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 162. NORWAY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 163. NORWAY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 164. NORWAY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 165. NORWAY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 166. POLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 167. POLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 168. POLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 169. POLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 170. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 171. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 172. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 173. QATAR BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 174. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 175. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 176. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 177. RUSSIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 178. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 179. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 180. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 181. SAUDI ARABIA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 182. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 183. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 184. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 185. SOUTH AFRICA BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 186. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 187. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 188. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 189. SPAIN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 190. SWEDEN BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 191. SWEDEN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 192. SWEDEN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 193. SWEDEN BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 194. SWITZERLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 195. SWITZERLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 196. SWITZERLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 197. SWITZERLAND BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 198. TURKEY BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 199. TURKEY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 200. TURKEY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 201. TURKEY BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 202. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 203. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 204. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 205. UNITED ARAB EMIRATES BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 206. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 207. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD BILLION)
TABLE 208. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD BILLION)
TABLE 209. UNITED KINGDOM BLEEDING DISORDERS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 210. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 211. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 212. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 213. GLOBAL BLEEDING DISORDERS TREATMENT MARKET RANKING, BY KEY PLAYER, 2022
TABLE 214. GLOBAL BLEEDING DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 215. GLOBAL BLEEDING DISORDERS TREATMENT MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 216. GLOBAL BLEEDING DISORDERS TREATMENT MARKET MERGER & ACQUISITION
TABLE 217. GLOBAL BLEEDING DISORDERS TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 218. GLOBAL BLEEDING DISORDERS TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 219. GLOBAL BLEEDING DISORDERS TREATMENT MARKET INVESTMENT & FUNDING
TABLE 220. GLOBAL BLEEDING DISORDERS TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 221. GLOBAL BLEEDING DISORDERS TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Alnylam Pharmaceuticals Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • CSL Behring
  • Emergent BioSolutions Inc.
  • Grifols International, S.A.
  • Kedrion S.p.A.
  • Novo Nordisk A/S
  • Octapharma AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Xenetic Biosciences, Inc.

Methodology

Loading
LOADING...